Asosiy kontentga oʻtish
AkademScholar

Kashfiyot

Xizmatlar

Identifikatsiya

Ishlab chiquvchilar uchun

Ekotizim

Muassasalar

National Center for Tuberculosis and Lung Disease

Nom variantlari: NCTBLD

Davlat:
GE
ROR:
https://ror.org/02kf03x09
3
h-indeks
19
Iqtiboslar
12
Asarlar
10
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
0120134520162017201820192020202120222024202520262016: Nashrlar 1, Iqtiboslar 02017: Nashrlar 0, Iqtiboslar 12018: Nashrlar 2, Iqtiboslar 02019: Nashrlar 0, Iqtiboslar 22020: Nashrlar 1, Iqtiboslar 22021: Nashrlar 2, Iqtiboslar 22022: Nashrlar 1, Iqtiboslar 22024: Nashrlar 2, Iqtiboslar 52025: Nashrlar 0, Iqtiboslar 22026: Nashrlar 0, Iqtiboslar 2

Iqtibos tarixi

0134520162017201820192020202120222024202520262016: Iqtiboslar 02017: Iqtiboslar 12018: Iqtiboslar 02019: Iqtiboslar 22020: Iqtiboslar 22021: Iqtiboslar 22022: Iqtiboslar 22024: Iqtiboslar 52025: Iqtiboslar 22026: Iqtiboslar 2

Nashr tarixi

01220162017201820192020202120222024202520262016: Nashrlar 12017: Nashrlar 02018: Nashrlar 22019: Nashrlar 02020: Nashrlar 12021: Nashrlar 22022: Nashrlar 12024: Nashrlar 22025: Nashrlar 02026: Nashrlar 0

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520162017201820192020202120222024202520262016: h-indeks 12017: h-indeks 12018: h-indeks 12019: h-indeks 12020: h-indeks 22021: h-indeks 22022: h-indeks 22024: h-indeks 32025: h-indeks 32026: h-indeks 3

Eng koʻp iqtibos qilingan asarlar

  1. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?20151 iqtibos
  2. Diagnostic Procedures, Diagnoses, and Treatment Outcomes of Patients with Presumptive Tuberculosis Pleural Effusion in Uzbekistan20211 iqtibos
  3. A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients20130 iqtibos
  4. Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study20150 iqtibos
  5. Outcomes of HIV-infected versus HIV-non-infected patients treated for drug-resistance tuberculosis: Multicenter cohort study20180 iqtibos
  6. Incidence Rate and Risk Factors for Tuberculosis among People Living with HIV: A 2015–2017 Cohort from Tashkent, Uzbekistan20210 iqtibos
  7. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study20240 iqtibos
  8. Effectiveness and Safety of Modified Fully Oral Nine-Month Treatment Regimens for Rifampicin-Resistant Tuberculosis: Prospective Cohort Study20240 iqtibos